RetractedArticleMolecular medicine reports2019

Lidocaine inhibits the progression of retinoblastoma in vitro and in vivo by modulating the miR‑520a‑3p/EGFR axis.

Weiyi Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.